SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001159036-22-000037
Filing Date
2022-05-10
Accepted
2022-05-10 16:07:23
Documents
14
Period of Report
2022-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K halo-20220510.htm   iXBRL 8-K 42017
2 EX-99.1 ex991q120228-k.htm EX-99.1 179739
6 halozymea23a.jpg GRAPHIC 701236
  Complete submission text file 0001159036-22-000037.txt   1319341

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20220510.xsd EX-101.SCH 1915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20220510_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20220510_pre.xml EX-101.PRE 12520
8 EXTRACTED XBRL INSTANCE DOCUMENT halo-20220510_htm.xml XML 10826
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 22909576
SIC: 2836 Biological Products, (No Diagnostic Substances)